ResMed EBITDA Margin 2010-2024 | RMD

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for ResMed (RMD) over the last 10 years. The current EBITDA margin for ResMed as of September 30, 2024 is .
ResMed EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-09-30 $4.81B $1.63B 33.99%
2024-06-30 $4.69B $1.54B 32.76%
2024-03-31 $4.58B $1.43B 31.17%
2023-12-31 $4.50B $1.35B 30.04%
2023-09-30 $4.38B $1.35B 30.88%
2023-06-30 $4.22B $1.33B 31.47%
2023-03-31 $4.02B $1.30B 32.35%
2022-12-31 $3.76B $1.23B 32.73%
2022-09-30 $3.63B $1.20B 33.21%
2022-06-30 $3.58B $1.19B 33.36%
2022-03-31 $3.54B $1.18B 33.36%
2021-12-31 $3.44B $1.17B 33.86%
2021-09-30 $3.35B $1.14B 33.98%
2021-06-30 $3.20B $1.10B 34.25%
2021-03-31 $3.09B $1.08B 34.84%
2020-12-31 $3.09B $1.07B 34.62%
2020-09-30 $3.03B $1.04B 34.46%
2020-06-30 $2.96B $0.99B 33.53%
2020-03-31 $2.89B $0.89B 30.65%
2019-12-31 $2.78B $0.82B 29.49%
2019-09-30 $2.70B $0.77B 28.57%
2019-06-30 $2.61B $0.73B 28.05%
2019-03-31 $2.53B $0.75B 29.54%
2018-12-31 $2.46B $0.71B 29.04%
2018-09-30 $2.41B $0.70B 28.90%
2018-06-30 $2.34B $0.66B 28.28%
2018-03-31 $2.27B $0.64B 28.10%
2017-12-31 $2.20B $0.61B 27.73%
2017-09-30 $2.13B $0.56B 26.31%
2017-06-30 $2.07B $0.54B 26.09%
2017-03-31 $2.03B $0.53B 26.08%
2016-12-31 $1.97B $0.52B 26.27%
2016-09-30 $1.89B $0.52B 27.52%
2016-06-30 $1.84B $0.52B 27.99%
2016-03-31 $1.77B $0.49B 27.40%
2015-12-31 $1.74B $0.49B 27.90%
2015-09-30 $1.71B $0.49B 28.36%
2015-06-30 $1.68B $0.48B 28.72%
2015-03-31 $1.64B $0.48B 29.45%
2014-12-31 $1.62B $0.48B 29.76%
2014-09-30 $1.58B $0.48B 30.25%
2014-06-30 $1.56B $0.48B 30.80%
2014-03-31 $1.56B $0.47B 30.03%
2013-12-31 $1.54B $0.46B 29.98%
2013-09-30 $1.53B $0.45B 29.27%
2013-06-30 $1.52B $0.43B 28.56%
2013-03-31 $1.47B $0.44B 29.80%
2012-12-31 $1.44B $0.42B 29.14%
2012-09-30 $1.39B $0.40B 28.55%
2012-06-30 $1.37B $0.38B 27.76%
2012-03-31 $1.34B $0.35B 26.44%
2011-12-31 $1.30B $0.34B 26.02%
2011-09-30 $1.28B $0.34B 26.33%
2011-06-30 $1.24B $0.34B 27.11%
2011-03-31 $1.19B $0.34B 28.08%
2010-12-31 $1.16B $0.33B 28.47%
2010-09-30 $1.13B $0.32B 28.10%
2010-06-30 $1.09B $0.30B 27.63%
2010-03-31 $1.05B $0.29B 27.64%
2009-12-31 $1.00B $0.28B 27.84%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $33.995B $4.685B
ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $194.987B 24.87
Stryker (SYK) United States $136.147B 30.68
Boston Scientific (BSX) United States $130.670B 37.57
EssilorLuxottica (ESLOY) France $110.026B 0.00
Medtronic (MDT) Ireland $102.570B 15.24
Haleon (HLN) United Kingdom $43.909B 28.53
Lonza Group Ag (LZAGY) Switzerland $42.293B 0.00
GE HealthCare Technologies (GEHC) United States $35.376B 18.35
Terumo (TRUMY) Japan $28.800B 40.67
Koninklijke Philips (PHG) Netherlands $23.527B 18.01
Zimmer Biomet Holdings (ZBH) United States $21.064B 13.41
Insulet (PODD) United States $17.996B 71.67
Baxter (BAX) United States $14.756B 9.60
Smith & Nephew SNATS (SNN) United Kingdom $10.838B 0.00
BellRing Brands (BRBR) United States $10.021B 40.32
Bio-Rad Laboratories (BIO) United States $9.125B 31.01
Demant (WILYY) Denmark $7.926B 0.00
Lantheus Holdings (LNTH) United States $6.392B 14.85
Prestige Consumer Healthcare (PBH) United States $3.886B 19.33
Haemonetics (HAE) United States $3.862B 18.85
ICU Medical (ICUI) United States $3.751B 35.71
Perrigo (PRGO) Ireland $3.510B 10.33
Envista Holdings (NVST) United States $3.103B 23.11
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
QuidelOrtho (QDEL) United States $2.894B 18.63
GN Store Nord (GNNDY) Denmark $2.864B 18.36
Neogen (NEOG) United States $2.605B 30.05
LeMaitre Vascular (LMAT) United States $2.074B 50.41
Green Thumb Industries (GTBIF) United States $1.630B 28.52
AtriCure (ATRC) United States $1.465B 0.00
InMode (INMD) Israel $1.444B 8.68
Maravai LifeSciences Holdings (MRVI) United States $1.371B 0.00
AdaptHealth (AHCO) United States $1.304B 9.32
BioLife Solutions (BLFS) United States $1.211B 0.00
Owens & Minor (OMI) United States $0.973B 7.60
CeriBell (CBLL) United States $0.958B 0.00
Curaleaf Holdings (CURLF) Canada $0.955B 0.00
Phibro Animal Health (PAHC) United States $0.883B 15.58
Evolus (EOLS) United States $0.688B 0.00
Omeros (OMER) United States $0.593B 0.00
VAREX IMAGING (VREX) United States $0.593B 26.15
Capricor Therapeutics (CAPR) United States $0.587B 0.00
Surmodics (SRDX) United States $0.572B 0.00
Verano Holdings (VRNOF) United States $0.445B 0.00
Cresco Labs (CRLBF) United States $0.429B 0.00
Quanterix (QTRX) United States $0.383B 0.00
ZimVie (ZIMV) United States $0.373B 31.44
Valneva SE (VALN) France $0.353B 0.00
Biote (BTMD) United States $0.313B 6.86
Viemed Healthcare (VMD) United States $0.312B 29.70
Canopy Growth (CGC) Canada $0.295B 0.00
Cerus (CERS) United States $0.293B 0.00
OraSure Technologies (OSUR) United States $0.283B 18.95
Sanara MedTech (SMTI) United States $0.276B 0.00
Zynex (ZYXI) United States $0.268B 56.00
High Tide (HITI) Canada $0.237B 98.00
Aurora Cannabis (ACB) Canada $0.225B 0.00
Utah Medical Products (UTMD) United States $0.211B 14.54
MacroGenics (MGNX) United States $0.200B 0.00
Sanuwave Health (SNWV) United States $0.188B 2.64
Organigram Holdings (OGI) Canada $0.184B 0.00
TerrAscend (TSNDF) Canada $0.181B 0.00
Brainsway (BWAY) Israel $0.169B 89.60
FitLife Brands (FTLF) United States $0.151B 19.04
Jin Medical (ZJYL) China $0.132B 0.00
TriSalus Life Sciences (TLSI) United States $0.110B 0.00
Quipt Home Medical (QIPT) United States $0.104B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.100B 0.00
Fonar (FONR) United States $0.096B 10.79
Veru (VERU) United States $0.092B 0.00
Exagen (XGN) United States $0.083B 0.00
Rockwell Medical (RMTI) United States $0.066B 34.17
InterCure (INCR) Israel $0.061B 0.00
Apyx Medical (APYX) United States $0.059B 0.00
Jushi Holdings (JUSHF) United States $0.054B 0.00
Modular Medical (MODD) United States $0.050B 0.00
Cytosorbents (CTSO) United States $0.048B 0.00
Safety Shot (SHOT) United States $0.042B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Allurion Technologies (ALUR) United States $0.018B 0.00
Nephros (NEPH) United States $0.016B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Innovative Eyewear (LUCY) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Trinity Biotech (TRIB) Ireland $0.006B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Agape ATP (ATPC) $0.005B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Sharps Technology (STSS) United States $0.003B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 12.82
SNDL (SNDL) Canada $0.000B 0.00